Fundraising Fox
🦊/People
Sign in

Filip Van den Wyngaert

Vice President Asset Management at TargED Biopharmaceuticals

Belgium

Find your path to Filip

363 people in our graph share verified history with Filip — schools, employers, funds. One of them is your warm intro.

Sam BlackmanunlockedFilip: together at GSK (2010–2012)
×3Filip: together at GSK
Filip: together at University of Antwerp
×6Filip: together at Vlerick Business School

Vice President Asset Management at TargED Biopharmaceuticals

Intro paths

→

In turn, Filip can intro founders to TargED Biopharmaceuticals's investors below.

TargED Biopharmaceuticals's investors · 8

Andera PartnersParis · since 2022BioGeneration VenturesNaarden · since 2022Curie CapitalAmsterdam · since 2022Fund+Leuven · $5.5M – $16.5M checks · since 2022Hadean VenturesOslo · since 2022InkefAmsterdam · since 2022RotripAmsterdamSunstone CapitalFrederiksberg

Co-founders at TargED Biopharmaceuticals

CMCoen Maas
Coen MaasCo-founder
SDSteven de Maat
Steven de MaatChief Scientific Officer
MV
Marc van MoorselDirector of Operations
KVKristof Vercruysse
Kristof VercruysseChief Executive Officer

Experience

  1. TargED BiopharmaceuticalsVP Asset Strategy & Business Operations TargED Biopharmaceuticalscurrent2025 — presentUtrecht
  2. SanofiBusiness Unit Head Pompe GSA; Rare Diseases2023 — 2025Frankfurt am Main, Hessen, Duitsland
  3. Sanofi GenzymeGlobal Brand Lead Cablivi; Rare Blood Disorders2020 — 2022Brussels, Boston
  4. Sanofi GenzymeEU Commercial Lead Cablivi, Rare Blood Disorders2018 — 2020Brussels, Amsterdam
  5. AblynxHead Global Commercial Strategy & Operations Cablivi2017 — 2018Gent
  6. AblynxHead Caplacizumab Business Unit2015 — 2017
  7. GSKGlobal commercial lead Rotarix2014 — 2015Brussels
  8. GSKProgram & Launch Lead Immuno-oncology and Chronic Disorders2011 — 2014Brussels
  9. Deloitte - PwCManagement Consultant - Health Care & Life Sciences2008 — 2010
  10. GlaxoSmithKline BiologicalsGlobal Study Manager Oncology2006 — 2008
  11. EORTCCRA2004 — 2005

Skills & more

PharmaceuticalsClinical ResearchClinical DevelopmentClinical TrialsLife SciencesBusiness StrategyManagement ConsultingProject Portfolio ManagementLifesciencesPharmaceutical IndustryProject ManagementOncology
+6 moreVaccinesCTMSGCPCROConsultingBiotechnology

From Filip's professional profile.

Frequently asked questions

Who is Filip Van den Wyngaert?
Vice President Asset Management at TargED Biopharmaceuticals
Where does Filip Van den Wyngaert work?
Filip Van den Wyngaert is Vice President Asset Management at TargED Biopharmaceuticals.
Where did Filip Van den Wyngaert go to school?
Filip Van den Wyngaert studied at Vlerick Business School (Executive Development Programme); PMP Certification; University of Antwerp (Master, Biomedical Sciences).

Same school

Shared employers